The application dimension of the White Light Endoscope for Medical segmentation divides the market into Diagnostic, Therapeutic, Surgical and Screening uses. Diagnostic endoscopy, which includes routine gastrointestinal and bronchial examinations, accounts for the largest share—approximately 40% of total revenue—driven by high procedure volumes and early‑detection initiatives. Therapeutic applications, such as polyp removal, hemostasis and stent placement, contribute roughly 25%; growth is linked to minimally invasive treatment protocols and reimbursement incentives. Surgical use, encompassing laparoscopic and transurethral procedures, represents about 20% of the market, reflecting the shift toward image‑guided operations that demand superior illumination. Screening, primarily population‑level cancer and colorectal programs, makes up the remaining 15%, supported by public‑health campaigns and aging demographics. Collectively, these application segments define the market’s demand curve, with each sub‑segment’s pricing, adoption rate and device turnover directly influencing overall market size.